Skip to content

Trifecta™ TF-23A

by St. Jude Medical, Inc.

Trifecta™ TF-23A is a Class III device made by St. Jude Medical, Inc., approved under FDA PMA P100029 on 20 Apr 2011 and listed in FDA GUDID since 23 Sep 2014 (UDI-DI 05414734052030), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

PMA P100029

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05414734052030 UDI-DI Date23 Sep 2014ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP100029 Date20 Apr 2011DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P100029 decided 20 Apr 2011 Active
  • FDA GUDID UDI-DI 05414734052030 listed 23 Sep 2014 Listed

Timeline

2 dated events

  1. Approved FDA PMA P100029
  2. Listed FDA GUDID 05414734052030

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Trifecta™
Generic name
Aortic open-surgery heart valve bioprosthesis
Model / Ref / Catalog
TF-23A
Primary DI / UDI-DI
05414734052030
PMA number
FDA product code
LWR
GMDN term
Aortic open-surgery heart valve bioprosthesis
Device class
Class III
GUDID distribution status
In Commercial Distribution
MRI safety
MR Conditional
Size
Outer Diameter — 23 Millimeter

Similar devices in this category

Other devices filed under Aortic open-surgery heart valve bioprosthesis.

Other devices from St. Jude Medical, Inc.

See all devices from St. Jude Medical, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Serial number
  • Expiration date
Other properties (9, all answered No)